Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

7.03
+0.13001.88%
Volume:42.31K
Turnover:286.02K
Market Cap:13.27M
PE:-0.81
High:7.29
Open:6.43
Low:6.06
Close:6.90
52wk High:26.64
52wk Low:5.00
Shares:1.89M
Float Shares:1.29M
Volume Ratio:1.45
T/O Rate:3.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.7319
EPS(LYR):-8.7319
ROE:-2174.98%
ROA:-247.30%
PB:-8.51
PE(LYR):-0.81

Loading ...

NASDAQ Trade Halt Continues Reason not Available at 06:55 Am

Reuters
·
Sep 14

Neurosense Therapeutics Ltd trading halted, news pending

TIPRANKS
·
Sep 12

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Sep 12

NeuroSense Therapeutics to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

Neurosense Therapeutics Ltd: to Effect Reverse Share Split of Co’s Ordinary Shares at Ratio of 1-for-20

THOMSON REUTERS
·
Sep 10

NeuroSense Therapeutics Effects 1-for-20 Reverse Stock Split on Sept. 14, 2026

Reuters
·
Sep 10

NeuroSense Therapeutics Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 03

Neurosense Therapeutics Ltd. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $8

THOMSON REUTERS
·
Sep 03

NeuroSense announces redesigned development plan for PrimeC

TIPRANKS
·
Aug 31

NeuroSense Targets Faster, Lower-Cost ALS Approval Path for PrimeC Under Revamped Development Plan

Reuters
·
Aug 31

NeuroSense Plans Head-to-Head PrimeC Trial Versus Mitsubishi Tanabe’s Edaravone in ALS

Reuters
·
Aug 31

Neurosense Unveils Accelerated, Capital-Efficient Strategy to Advance Primec Toward Potential Approval in ALS

THOMSON REUTERS
·
Aug 31

NeuroSense Therapeutics Shareholders Authorized Board to Pursue Reverse Stock Split Range 1-for-4 to 1-for-40

Reuters
·
Aug 28

NeuroSense Announces Shareholder Letter Availability

Reuters
·
Aug 13

NeuroSense Targets December 2026 Canada Filing for PrimeC ALS Drug Amid Phase 3 Paragon Preparations

Reuters
·
Aug 13

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)

TIPRANKS
·
Aug 11

NeuroSense sees December 2026 as filing date for NDS for PrimeC

TIPRANKS
·
Aug 06

NeuroSense Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 01

NeuroSense Amends JonesTrading Equity Distribution Agreement for up to $3.79 Million Share Sales

Reuters
·
Aug 01

Neurosense Therapeutics Ltd Expected to Post Breakeven Results a Share - Earnings Preview

Reuters
·
Jul 28